Analyst Research Report Snapshot

Title:

E-THERAPEUTICS - MAKING NETWORK PHARMACOLOGY WORK

Price:

$10.00

Provider:

Edison Investment Research

Date:

30 Jun 2014

Pages:

12

Type:

AcrobatPDF

Companies referenced:

ETXP.L

Available for Immediate Download
Summary:

e-Therapeutics is a pioneer in network pharmacology, a novel approach to drug discovery that may result in faster and less risky development. The two lead programmes, ETS2101 (dexanabinol) in various cancers and ETS6103 (tramadol) in major depressive disorder, are progressing through early-stage clinical trials. Positive results would provide major value inflection points and facilitate out-licensing deals. The company is well funded, through to 2019, following the £38.9m (net) raise in March 2013.

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.